FDA Recalls Cymbalta Generic Over Presence of Carcinogens
Oct 23, 2024
The U.S. Food and Drug Administration (FDA) has announced a substantial recall of duloxetine, the generic form of the widely used antidepressant Cymbalta. The recall comes in response to concerns over the presence of a potentially harmful chemical impurity.
https://www.riverfronttimes.com/news/fda-recalls-cymbalta-generic-over-presence-of-carcinogens-43548147
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service